| Popis: |
Essure® (Bayer AG, Leverkusen, Germany) is a minimally invasive form of irreversible contraception designed for women. In 2002, this method was the first hysteroscopic sterilization method to be approved for use by the United States Food and Drug Association (FDA) [1–3]. The transcervical route offered an attractive alternative to the widely used transabdominal approach of sterilization. Moreover, it does not require abdominal wall incisions or general anaesthesia and can be performed on out-patient basis [4, 5]. Since its introduction on the market, more than 750,000 devices were sold [6, 7]. |
